Kure It News 

Kure It Cancer Research (Kure It) announced that two researchers from the University of California San Diego and City of Hope will be receiving grants for their research proposals for kidney and bile duct cancers.

A team of researchers from SWOG Cancer Research Network, a cancer clinical trials group funded by the National Cancer Institute (NCI), have shown that they can use methylation patterns in cell-free DNA (cfDNA) extracted from blood samples to predict which patients with muscle-invasive bladder cancer are likely to benefit from chemotherapy before their surgery.

Kure It Cancer Research has awarded a $200,000 grant to support the work of Scott Haake, MD, assistant professor of Medicine in the Division of Hematology and Oncology. Haake’s research involves how RNA sequence-based biomarkers can identify targetable biologic drivers of kidney cancer. Kure it Inc. is a nonprofit that funds translational research projects focused on kidney cancer and other underfunded cancers.

A world-renowned physician-scientist in the field of renal cell carcinoma (RCC), W. Kimryn Rathmell, MD, PhD of Vanderbilt University Medical Center, offers to share the impact of two AACR-supported research grants – 2018 AACR-Kure It Research Grant for Immunotherapy in Kidney Cancer and 2010 Landon Foundation-AACR INNOVATOR Award for Research in Personalized Cancer Medicine, on her career and research.